Pekin Hardy Strauss’s Celgene Corp CELG Stock Holding History

Pekin Hardy Strauss’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,520	Closed	-$350K	–	237
2019 Q3	$350K	Hold	3,520	–	–	0.07%	160
2019 Q2	$325K	Buy	3,520 +300	+9%	+$28.5K	0.06%	155
2019 Q1	$304K	Sell	3,220 -1,035	-24%	-$90.5K	0.02%	155
2018 Q4	$273K	Sell	4,255 -2,125	-33%	-$157K	0.05%	156
2018 Q3	$571K	Hold	6,380	–	–	0.1%	125
2018 Q2	$507K	Buy	+6,380	New	+$530K	0.1%	127

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Pekin Hardy Strauss's CELG Position: Q4 2019 in Review

Pekin Hardy Strauss sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,520 shares — an estimated $350K sold.

Pekin Hardy Strauss first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $571K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Pekin Hardy Strauss reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Pekin Hardy Strauss sold 3,520 Celgene Corp shares in Q4 2019, an estimated $350K.
Pekin Hardy Strauss first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
Pekin Hardy Strauss's Celgene Corp position peaked at $571K in Q3 2018.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pekin Hardy Strauss's 13F filing for Q4 2019, filed 12 Feb 2020.